PROTAGONIST THERAPEUTICS, INC.

IPO

Protagonist Therapeutics Inc.

Public · Newark, United States · Founded 2015 · $56.8M raised

Headquarters
Newark, California
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$56.8M
Last Round
$1.5M GrantAug 2018
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 1 investor for this company. The full record is or through the API.

About

R&D company with 4 SBIR/STTR awards from Department of Health and Human Services.

Summary

PROTAGONIST THERAPEUTICS, INC. is a Biotech company based in Newark, United States, founded in 2015. It has raised $56.8M in total across 4 rounds, most recently a $1.5M Grant round in Aug 2018. Investors include Johnson & Johnson Innovation.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

GrantSBIR Phase II (NIH)Aug 2018
$1.5M

Sign up to see all 5 events

Funding: Series C through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PROTAGONIST THERAPEUTICS, INC. on Indexed.vc
<a href="https://indexed.vc/companies/protagonist-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/protagonist-therapeutics-inc" alt="PROTAGONIST THERAPEUTICS, INC. on Indexed.vc" width="260" height="76" /></a>